|
The valve of the sheath was leaking from the beginning and allowed blood leakage, despite a 0.035" terumo guidewire being in place.Consequently, the position had to be abandoned, and the sheath was replaced with a new destino reach.Device valve leakage / blood leakage; patient experienced blood loss.Issue was identified during mid bevar procedure, during cannulation of the target vessel.Terumo 0.035" guidewire used in combination with the oscor product.The sheath was removed and replaced with another destino reach.There was an approximate 10-minute procedural delay.No patient harm reported, and no extended hospitalization reported.
|
|
Conclusion not yet available, evaluation in process.A follow-up will be submitted as soon as the investigation is complete.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.
|